#Order
Order Extending the Stay Period to September 30, 2026 was filed.
Source: Order Extending the Stay Period to September 30, 2026
Valeo Pharma Inc. Group
FollowActive
- Proceeding
- CCAACompanies' Creditors Arrangement Act, ss. 4, 6, 11, 11.02, 11.03, 11.51, 11.52, 11.7 and 23
- File
- 500-11-064718-246
OverviewSummary updated
Valeo Pharma Inc. and the other companies in its group are under Companies' Creditors Arrangement Act protection in the Superior Court of Québec, in a proceeding carried under court file no. 500-11-064718-246. The proceeding began with an initial order made at Montreal on October 1, 2024. A further application in the file was filed at Montréal on October 10, 2024. The case remains active.
Proceedings AIAsk this case — answers cite the filings
Case updates63 dated entries
#Report
The officer filed report no. Sixth Monitor's Report. The Residual Entities are in an orderly wind-down, with the Monitor collecting remaining Excluded Assets (sales tax receivables and Health Services Fund amounts) and administering receipts/disbursements pending termination of the CCAA proceedings or eventual bankruptcy.
Source: Sixth Report of the Monitor
60 earlier updates, back to 1 October 2024 — subscribers.
Parties
Debtor
Valeo Pharma Inc. Group
Monitor
EY
Bench and counselPer the orders and service lists on the record
Bench
| Judge | Court | On this docket | Cases on record |
|---|---|---|---|
| Justice Collier | Superior Court of Québec | 19 orders, Oct 2024 – Oct 2025 | 21 cases on record |
Counsel of record
| Party | Counsel | First seen | Source |
|---|---|---|---|
| MonitorEY | McCarthy Tétrault LLP | 1 Oct 2024 | Order · 1 Oct 2024 |
| ApplicantValeo Pharma Inc. Group | McMillan LLP | 1 Oct 2024 | Application · 11 Nov 2024 |
| Interim lender | Torys LLP | 14 Nov 2024 | Order · 14 Nov 2024 |
| Purchaser | Mintz LLP · Thornton Grout Finnigan LLP | 24 Jan 2025 | Order · 4 Feb 2025 |
| CreditorAccord Financial Inc | Kugler Kandestin LLP Previously Torys LLP (last seen 2 Oct 2024) | 2 Oct 2024 | Service list · 30 Dec 2024 |
| CreditorEthypharm | Woods LLP | 30 Dec 2024 | Service list · 30 Dec 2024 |
| CreditorEthypharm Inc | Woods LLP | 10 Oct 2024 | Application · 10 Oct 2024 |
| CreditorGOVERNMENT OF BRITISH COLUMBIA a / s Justice, Health and Revenue Legal Services Branch, Ministry of Attorney General | Tiger Bannon LLP | 30 Dec 2024 | Service list · 30 Dec 2024 |
| CreditorSagard Healthcare Partners (Delaeware), LP | Torys LLP | 30 Dec 2024 | Service list · 30 Dec 2024 |
| CreditorSagard Healthcare Partners (Delaware) LP | Torys LLP | 2 Oct 2024 | Order · 2 Oct 2024 |
Capital structureAs asserted in the filings
| Priority class | Creditor | Amount | Source |
|---|---|---|---|
| Secured | Sagard Healthcare Royalty Partners (Delaware), LPUSD amount converted to CAD at 1.3504 (Note 1); listed as secured creditor S-1 — debtor: Valeo Pharma Inc. · as of 1 Oct 2024 | $33.5M | List of Creditors as at October 1st, 2024, updated to October 8, 2024 |
184 more claims across lower-ranking classesSubscribe to view
Sale processAs stated in the filings
2 transactions · 1 closed · 1 proposed — Xediton Transaction closed and Residual Entities in wind-downSixth Report of the Monitor · 25 Jun 2026
| Purchaser | Price | Status | Source |
|---|---|---|---|
| Xediton Pharmaceuticals Inc.the terms of a reverse vesting order · asset sale · agreement 17 Jan 2025 | Subscribers | Closed4 Feb 2025 | Fifth Report of the Monitor |
| referred to only as 'the Purchaser'; not named in this excerptthe Proposed Transaction (Share Purchase Agreement) · share sale · ResidualCo: ResidualCo | Subscribers | Proposed | 04 Supplement to the Third Report of the… |
AdvisorsErnst & Young Inc. (financial advisor)First Report of the Monitor, dated October 10, 2024
Closing termsClosing steps to occur in the manner, order and sequence specified in Schedule E of the Purchase Agreement5 Approval and reverse vesting order - February 4, 2025
Sealed materialsunredacted Purchase Agreement; unredacted Purchase Agreement and amendment theretoList of Exhibits and Exhibits R-1 to R-5
RecoveriesAs declared or paid
Unsecured creditors: no distribution. Accord Financial Inc. paid in full · Sagard and Accord a distribution.Estimated03 Third Report of the Monitor · 23 Jan 2025
| Class | Creditor | Claims | Recovery | Basis | Source |
|---|---|---|---|---|---|
| Secured | Accord Financial Inc. | — | paid in full | Estimatedper the debtor | Application for Approval Assignment and Vesting Order, and other orders · 18 Jan 2025 |
| Secured | Sagard and Accord | — | a distribution | Finalper the monitor | Fourth Report of the Monitor · 5 May 2025 |
| Unsecured | — | — | no distribution | Estimatedper the monitor | 03 Third Report of the Monitor · 23 Jan 2025 |
| Equity | holders of Valeo's common shares | — | no distribution | per the debtor | Application by the Attorney General of Canada for the Issuance of an… · 28 Feb 2025 |
Each row is one filing's statement, copied as it reads and never computed. "Estimated" is the officer's forecast; "Under the plan" is the plan's or proposal's own term; "Final" is a declared or paid distribution; a row with no chip states no footing. A range is the two numbers stated; "of proven claims" is the document's own denominator.
2 stated figures across 4 outcomes, each sourcedSubscribe to view
Estate financialsReported figures — never derived
The debtor’s own statement of its total assets and liabilities at filing is in the record — Subscribers
Cumulative receipts
$444K
As at 25 Jun 2026Sixth Report of the Monitor
3 more reported figures, as at 25 Jun 2026Subscribe to view
Documents
63 filings
| Date | Document | File |
|---|---|---|
Minutes of the Hearing of June 30, 2026 (in French)
| PDF · Subscribers | |
Order Extending the Stay Period to September 30, 2026
| PDF · Subscribers | |
Sixth Report of the Monitor
| PDF · Subscribers | |
| Application for an Extension Order to September 30, 2026 | PDF · Subscribers | |
Minutes of the Hearing of October 31, 2025 (in French)
| PDF · Subscribers | |
Order (i) extending the Stay Period to June 30, 2026, (ii) terminating the CCAA proceedings, and (iii) discharging the Monitor
| PDF · Subscribers | |
Fifth Report of the Monitor
| PDF · Subscribers | |
| Application for the issuance of an order (i) extending the Stay Period, (ii) terminating the CCAA proceedings, and (iii) discharging the Monitor | PDF · Subscribers | |
Amended and Restated Certificate of the Monitor
| PDF · Subscribers | |
Extension Order to October 31, 2025
| PDF · Subscribers | |
Minutes of the Hearing of May 9, 2025 (in French)
| PDF · Subscribers | |
Fourth Report of the Monitor
| PDF · Subscribers | |
| Application for the Issuance of an Interim Extension Order to May 9, 2025 and an Extension Order to October 31, 2025 | PDF · Subscribers | |
Order – Interim Extension of the Stay Period to May 9, 2025
| PDF · Subscribers | |
Court of Appeal Judgment on Leave to Appeal an Approval and Reverse Vesting Order by Attorney General of Canada
| PDF · Subscribers | |
Minutes of Hearing of March 4, 2025 (in French)
| PDF · Subscribers | |
| Order Extending the Delay to File an Application for Leave to Appeal and Notice of Appeal with the Court of Appeal of Québec | PDF · Subscribers | |
Application by the Attorney General of Canada for the Issuance of an Order Extending the Delay to File an Application for Leave to Appeal and Notice of Appeal
| PDF · Subscribers | |
| Attorney General of Canada Application for Leave to Appeal from an Order made under the CCAA and the WEPPA | PDF · Subscribers | |
| Attorney General of Canada Notice of Appeal | PDF · Subscribers | |
Reasons for Orders issued on February 4, 2025, pursuant to the CCAA
| PDF · Subscribers | |
Certificate of the Monitor - February 6, 2025
| PDF · Subscribers | |
13 Minutes of Hearing - February 4, 2025 (en français)
| PDF · Subscribers | |
14 Order of cancellation and removal - February 4, 2025 (en français)
| PDF · Subscribers | |
16 Extension Order and Increased Monitor Powers - February 4, 2025
| PDF · Subscribers | |
5 Approval and reverse vesting order - February 4, 2025
| PDF · Subscribers | |
12 Minutes of Hearing - February 3, 2025 (en français)
| PDF · Subscribers | |
04 Supplement to the Third Report of the Monitor (February 1st, 2025)
| PDF · Subscribers | |
Amended List of Exhibits and Exhibits R-1 to R-6 (January 31, 2025)
| PDF · Subscribers | |
11 Order extending the stay period up to February 4, 2025
| PDF · Subscribers | |
03 Third Report of the Monitor, dated January 23, 2025
| PDF · Subscribers | |
10 Order extending the stay period
| PDF · Subscribers | |
Application for Approval Assignment and Vesting Order, and other orders
| PDF · Subscribers | |
List of Exhibits and Exhibits R-1 to R-5
| PDF · Subscribers | |
| Redacted Share Purchase Agreement and Amendment - January 17, 2025 | PDF · Subscribers | |
Application for an order extending the stay period
| PDF · Subscribers | |
Service List
| PDF · Subscribers | |
Corrected Order Extending the Stay Period and Amending the Key Employee Retention Plan (KERP)
| PDF · Subscribers | |
Minutes of Hearing, including an Order regarding an AMF demand (paragraph 13 - ARIO)
| PDF · Subscribers | |
Order on Motion by Ethypharm for Rank on Security (in French)
| PDF · Subscribers | |
Amended Application for (i) the Issuance of an Order Extending the Stay Period and (ii) to Amend the Key Employee Retention Plan (KERP)
| PDF · Subscribers | |
Second Report of the Monitor, dated November 10, 2024
| PDF · Subscribers | |
| Motion by Ethypharm Inc. for Rank on Security (in french) | PDF · Subscribers | |
| Non-disclosure agreement (NDA) Form | PDF · Subscribers | |
Teaser
| PDF · Subscribers | |
| Judgment motivating the issuance of the Amended and Restated Initial Order (ARIO) of October 11, 2024 dated October 15, 2024 | PDF · Subscribers | |
Amended and Restated Initial Order, extending the Stay of Proceedings to November 15, 2024
| PDF · Subscribers | |
| Globe and Mail Ad, published on October 11 and 18, 2024 | PDF · Subscribers | |
| La Presse+, annonce publiée les 11 et 18 octobre 2024 | PDF · Subscribers | |
Order on a motion relating to inventories held on consignment (in French)
| PDF · Subscribers | |
Procedures for the Sale and Investor Solicitation Process (Bidding Procedures) (approved by the Court on October 11, 2024)
| PDF · Subscribers | |
Sale and Investor Solicitation Process Order
| PDF · Subscribers | |
First Report of the Monitor, dated October 10, 2024
| PDF · Subscribers | |
Motion by Ethypharm Inc. for Inventories Held on Consignment (in French)
| PDF · Subscribers | |
Amended Application for the Issuance of (I) An Initial Order, (II) An Amended and Restated Initial Order, and (III) An Order Approving a Sale and Investment Solicitation Process, dated October 9, 2024
| PDF · Subscribers | |
Exhibits R-26 to R-31
| PDF · Subscribers | |
| Notice to Creditors | PDF · Subscribers | |
Judgment motivating the issuance of the Initial Order of October 1st, 2024
| PDF · Subscribers | |
Initial Order
| PDF · Subscribers | |
List of Creditors as at October 1st, 2024, updated to October 8, 2024
| PDF · Subscribers | |
| Appendix C | PDF · Subscribers | |
Report of the Proposed Monitor
| PDF · Subscribers | |
Application for the Issuance of (I) An Initial Order, (II) An Amended and Restated Initial Order, and (III) An Order Approving a Sale and Investment Solicitation Process, dated September 27, 2024
| PDF · Subscribers | |
Filing titles and dates are public, and so is each filing's own page. The figures read from them are for subscribers.
CiteProceedings., “Valeo Pharma Inc. Group” (CCAA), Superior Court of Québec. Retrieved 20 September 2026, https://proceedings.ca/case/valeo-pharma-inc-group